phase readout
saveNCT04419649: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Takeda. Phase: PHASE2. Conditions: Myelodysplastic Syndromes, Cytopenia
view source ↗
comments(0)
5-min edit window · permanent after that